Found: 13
Select item for more details and to access through your institution.
Dapagliflozin treatment of patients with chronic kidney disease without diabetes across different albuminuria levels (OPTIMISE-CKD).
- Published in:
- Clinical Kidney Journal, 2024, v. 17, n. 8, p. 1, doi. 10.1093/ckj/sfae100
- By:
- Publication type:
- Article
Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006-2013.
- Published in:
- Diabetologia, 2016, v. 59, n. 8, p. 1692, doi. 10.1007/s00125-016-3971-y
- By:
- Publication type:
- Article
Lower heart failure and chronic kidney disease risks associated with sodium‐glucose cotransporter‐2 inhibitor use in Japanese type 2 diabetes patients without established cardiovascular and renal diseases.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, p. 19, doi. 10.1111/dom.14119
- By:
- Publication type:
- Article
Lower heart failure and chronic kidney disease risks associated with sodium‐glucose cotransporter‐2 inhibitor use in Japanese type 2 diabetes patients without established cardiovascular and renal diseases.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, p. 19, doi. 10.1111/dom.14119
- By:
- Publication type:
- Article
Dapagliflozin and cardiovascular mortality and disease outcomes in a population with type 2 diabetes similar to that of the DECLARE‐TIMI 58 trial: A nationwide observational study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 5, p. 1136, doi. 10.1111/dom.13627
- By:
- Publication type:
- Article
Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2‐inhibitors versus other glucose‐lowering agents in real‐world clinical practice: Results from the CVD‐REAL study.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 1983, doi. 10.1111/dom.13299
- By:
- Publication type:
- Article
Association Between Paradoxical HDL Cholesterol Decrease and Risk of Major Adverse Cardiovascular Events in Patients Initiated on Statin Treatment in a Primary Care Setting.
- Published in:
- Clinical Drug Investigation, 2016, v. 36, n. 3, p. 225, doi. 10.1007/s40261-015-0372-9
- By:
- Publication type:
- Article
Cross-sectional and longitudinal analyses of the association between lung function and exercise capacity in healthy Norwegian men.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Long-term predictors of stroke in healthy middle-aged men.
- Published in:
- International Journal of Stroke, 2018, v. 13, n. 3, p. 292, doi. 10.1177/1747493017730760
- By:
- Publication type:
- Article
Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01521-9
- By:
- Publication type:
- Article
Sodium–glucose cotransporter 2 inhibitors compared with other glucose‐lowering drugs in Japan: Subanalyses of the CVD‐REAL 2 Study.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 1, p. 67, doi. 10.1111/jdi.13321
- By:
- Publication type:
- Article
Usefulness of Heart Failure Categories Based on Left Ventricular Ejection Fraction.
- Published in:
- Journal of the American Heart Association, 2024, v. 13, n. 8, p. 1, doi. 10.1161/JAHA.123.032257
- By:
- Publication type:
- Article
Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10.
- Published in:
- 2018
- By:
- Publication type:
- letter